How Do You Make Money In Private Deals?
As investors, there’s one question we should know the answer to before committing any funds… No, it’s not the valuation or the deal terms (although…
As investors, there’s one question we should know the answer to before committing any funds… No, it’s not the valuation or the deal terms (although…
While it’s a cynical play, these chipmakers are profiting from unprecedented circumstances If you’ve been paying attention to used car prices, you might have noticed…
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising pInovio Pharmaceuticals went from being…
When it comes to psychedelics, today’s article notes that “While this industry is still in its early stages, the promising potential of psychedelic medicine drug…
At the recent Global Financial Summit, two former Wall Street professionals shared their picks for innovative stocks to buy for the opportunity to profit from…
Today’s article highlights two clinical-stage biopharmaceutical stocks that analysts expect to more than double in the coming months — one engaged in discovering and developing…
After a week that saw mostly strong earnings reports from big pharma companies, an Alzheimer’s conference that moved stocks, and a slew of IPOs of…
Smaller-cap companies have had a good 12 months, and the author of today’s article notes that “the return picture over the trailing three-year period suggests…
With just a few days remaining in July, the FDA has approved four novel drugs this month, including a treatment for a parasitic “sleeping sickness”…
“All of these companies are working on new drugs that could be worth billions, and successes with them would push their stock prices through the…